Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FNVER
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,714
Award facts
- Contract value 100% obligated
- $31,714.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3ml) with a ceiling value of $31,714.28. The contract employs firm fixed pricing with an ultimate completion date of July 30, 2025. This award is classified as a competitive delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order supports the DLA's medical supply chain operations, which provides pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for military and veteran healthcare needs, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The award of Ozempic, a diabetes medication, reflects the company's demonstrated capability to fulfill federal procurement requirements for specialized pharmaceutical products through open competition. This transaction represents one of numerous delivery orders executed under the parent SPE2DX contract vehicle, demonstrating the flexible procurement framework supporting ongoing military healthcare pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB25FNVER?
SPE2DB25FNVER was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FNVER worth?
The government has obligated $31,714 on SPE2DB25FNVER.
Is contract SPE2DB25FNVER an order under another contract?
Yes. SPE2DB25FNVER is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVER competed?
The extent of competition for SPE2DB25FNVER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award